Tags

Type your tag names separated by a space and hit enter

The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm.
JAMA Intern Med. 2020 08 01; 180(8):1118-1119.JIM

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

DeJong C
Department of Medicine, University of California, San Francisco.
Wachter RM
Department of Medicine, University of California, San Francisco.

MeSH

BetacoronavirusCOVID-19Coronavirus InfectionsHumansHydroxychloroquineInternetPandemicsPneumonia, ViralSARS-CoV-2United StatesCOVID-19 Drug Treatment

Pub Type(s)

Letter
Comment

Language

eng

PubMed ID

32347894

Citation

DeJong, Colette, and Robert M. Wachter. "The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm." JAMA Internal Medicine, vol. 180, no. 8, 2020, pp. 1118-1119.
DeJong C, Wachter RM. The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm. JAMA Intern Med. 2020;180(8):1118-1119.
DeJong, C., & Wachter, R. M. (2020). The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm. JAMA Internal Medicine, 180(8), 1118-1119. https://doi.org/10.1001/jamainternmed.2020.1853
DeJong C, Wachter RM. The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm. JAMA Intern Med. 2020 08 1;180(8):1118-1119. PubMed PMID: 32347894.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm. AU - DeJong,Colette, AU - Wachter,Robert M, PY - 2020/4/30/pubmed PY - 2020/9/25/medline PY - 2020/4/30/entrez SP - 1118 EP - 1119 JF - JAMA internal medicine JO - JAMA Intern Med VL - 180 IS - 8 SN - 2168-6114 UR - https://www.unboundmedicine.com/medline/citation/32347894/full_citation DB - PRIME DP - Unbound Medicine ER -